top of page

Conclusions & Recommendations

25.3.4 - Next steps for Zithromax® decision-making in districts with persistent (Category 1) & recrudescent (Category 2) trachoma

Conclusion/Recommendation:

TEC recommends that ITI Management track Category 1 & 2 requests, TEC allocation decisions in those districts, and lessons learned as this new TEC guidance is implemented

Action:

This is ongoing.

TEC 25

2021

alternative treatment strategies, persistence, recommendations for ITI management, Zithromax® donation criteria

25.4.1 - Future TEC Meetings

Conclusion/Recommendation:

TEC 26: March 29-31, 2022 in London, UK – This meeting will focus on reconsidering TEC decisions for 2022 in Category 1 & 2 districts. Participants will include TEC, implementing partners and donors and program managers in countries with 2022 Applications in Category 1 & 2 districts that would like to propose a different strategy

Action:

No action required

TEC 25

2021

TEC meeting management

25.4.2 - Future TEC Meetings

Conclusion/Recommendation:

TEC 27: June 13 – 16, 2022 in Atlanta, GA, USA – an extra day has been added to allow more discussion time for Category 1 & 2 district decision-making.

Action:

No action required

TEC 25

2021

TEC meeting management

25.4.3 - Future TEC Meetings

Conclusion/Recommendation:

TEC 28: November 15 – 17, 2022 in Cape Town, South Africa – suggested agenda items include:
- Reviewing data from co-administration trials
- Updates from REACH trials (particularly Côte d’Ivoire, ideally including participation by the national program coordinator)
- A focus on Antimicrobial Resistance (AMR) monitoring and how it may affect communication between TEC members and partners

Action:

No action required

TEC 25

2021

TEC meeting management

24.1.1 - General Recommendations

Conclusion/Recommendation:

Include district-level data on infection, where available, to provide a more complete picture of trachoma in these areas (using publicly-available data and/or with permission from the MOH/researchers)

Action:

A new column to track this has been added to the TEMFs and publicly-available data is included in the Notes column on the Zithromax® Applications

TEC 24

2021

alternative indicators (Ct, serology), TEC meeting management

24.1.2 - General Recommendations

Conclusion/Recommendation:

include Zithromax® requests for research as rows on the applications (e.g., REACH; Stronger SAFE; KETFO)

Action:

A research request form has been added to the surgery request form to track these requests with greater detail

TEC 24

2021

TEC meeting management, research

24.1.3 - General Recommendations

Conclusion/Recommendation:

include regional prevalence maps in the TEC book, behind each regional tab, so that the cross-border situation can be taken into account when reviewing applications

Action:

These regional prevalence maps will be included beginning TEC 27

TEC 24

2021

TEC meeting management, COVID

24.1.4 - General Recommendations

Conclusion/Recommendation:

add the definition of coverage to the ‘cheat sheet’

Action:

The definition of Zithromax® coverage has been edited and is included on the TEC cheat sheet

TEC 24

2021

TEC meeting management, coverage

24.1.5 - General Recommendations

Conclusion/Recommendation:

add more details regarding requests for Zithromax® post-TT surgery (funders and implementing partners)

Action:

This information is being collected in the 2023 Zithromax® for TT-Surgery application form.

TEC 24

2021

TEC meeting management, trichiasis

24.10.1 - Peru

Conclusion/Recommendation:

TEC notes that despite several consecutive years of approving the Zithromax® request, MDA has not yet started. TEC recommends that ITI continue to monitor this situation closely and follow-up to ensure the MOU is signed.

Action:

ITI presented on these challenges in September 2021 during the PAHO Americas meetings and continues to discuss the challenges with PAHO and the MOH in Peru. ITI and PAHO hope that an agreement to ship Zithromax® via PAHO will replace the highly bureaucratic MOU process, which has been stalled for several years.

TEC 24

2021

Americas

Peru

recommendations for ITI management

International Trachoma Initiative

330 West Ponce de Leon Avenue

Decatur, GA 30030 

Phone:

+1 800 765 7173
+1 404 371 0466
Fax:

+1 404 371 1087

  • Instagram
  • Facebook
  • Twitter
  • YouTube
bottom of page